Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Archit Organosys is engaged in the business of dealing and manufacturing of chemicals. It's products include Mono Chloco Acetic Acid and Ethyle Acetate
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
ARCHIT ORGANOSYS LTD. - 524640 - Board Meeting Outcome for Approval Of Unaudited Standalone Financial Results Along With Statement Of Assets And Liabilities And Cash Flow Statement Of The Company For The Quarter And Half Year Ended On 30Th September, 2024. | Download
ARCHIT ORGANOSYS LTD. - 524640 - Board Meeting Outcome for Approval Of Unaudited Standalone Financial Results Along With Statement Of Assets And Liabilities And Cash Flow Statement Of The Company For The Quarter And Half Year Ended On 30Th September, 2024. | Download
Final • Div/Share: ₹ 0.5
Increased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 1.38%